---
id: 081
title: Bacterial Meningitis Empiric Therapy
category: clinical_syndromes
subcategory: meningitis
tags: [bacterial-meningitis, empiric-therapy, vancomycin, ceftriaxone, dexamethasone]
difficulty: medium
---

## Question

What is the empiric therapy for bacterial meningitis by age? Use the **"Vanc + Cef + DEXA for Adults"** mnemonic.

## Answer

### **"Vanc + Cef + DEXA for Adults" Mnemonic:**

**Vanc:** Vancomycin (for MRSA, pen-resistant *S. pneumoniae*)
**Cef:** Ceftriaxone or cefotaxime (for *S. pneumoniae*, *N. meningitidis*, *H. influenzae*)
**DEXA:** Dexamethasone 10mg IV q6h × 4 days (give BEFORE or WITH first antibiotic dose)

### **Empiric Therapy by Age:**

| Age Group | Likely Pathogens | Empiric Regimen |
|-----------|------------------|-----------------|
| **Neonate (<1 month)** | *Strep agalactiae* (GBS), *E. coli*, *Listeria* | **Ampicillin + cefotaxime** (or gent) |
| **1-3 months** | GBS, *E. coli*, *Listeria*, *S. pneumoniae*, *N. meningitidis* | **Vancomycin + cefotaxime + ampicillin** |
| **3 months-50 years** | ***S. pneumoniae***, ***N. meningitidis*** | **Vancomycin + ceftriaxone + dexamethasone** |
| **>50 years** | *S. pneumoniae*, *N. meningitidis*, ***Listeria***, Gram-negatives | **Vancomycin + ceftriaxone + ampicillin + dexamethasone** |
| **Immunocompromised** | Above + *Listeria*, *Pseudomonas* | **Vancomycin + cefepime + ampicillin** |

### **Dosing (Adults):**

| Drug | Dose | Notes |
|------|------|-------|
| **Vancomycin** | 15-20 mg/kg IV q8-12h | Target trough 15-20 µg/mL |
| **Ceftriaxone** | **2g IV q12h** (meningitis dosing) | Higher than usual 1-2g daily |
| **Ampicillin** | 2g IV q4h | For *Listeria* coverage (>50 years, immunocompromised) |
| **Dexamethasone** | **10mg IV q6h × 4 days** | Give BEFORE or WITH first antibiotic |

## Key Points

### **Dexamethasone Use:**

**Indication:**
- Suspected *S. pneumoniae* meningitis in adults

**Timing:**
- **MUST give BEFORE or WITH first antibiotic dose** (within 15 minutes)
- If given after antibiotics → **no benefit**

**Benefits:**
- ↓ Mortality in pneumococcal meningitis
- ↓ Neurologic sequelae (hearing loss)

**Duration:** 10mg IV q6h × 4 days (discontinue if not *S. pneumoniae*)

### **Add Ampicillin if:**
- Age >50 years (*Listeria* risk)
- Immunocompromised
- Pregnant
- Alcoholism
- Chronic liver disease

**Rationale:** Cephalosporins do NOT cover *Listeria* → need ampicillin

### **Add Cefepime (instead of ceftriaxone) if:**
- Recent neurosurgery
- CSF shunt
- Head trauma
- *Pseudomonas* risk

### **Special Situations:**

**Post-neurosurgery/CSF shunt:**
- Vancomycin + **cefepime** or **meropenem** (for *Pseudomonas*, resistant Gram-negatives)

**Basilar skull fracture:**
- Vancomycin + ceftriaxone (for *S. pneumoniae*)

**HSV encephalitis (empiric while awaiting PCR):**
- **Add acyclovir 10 mg/kg IV q8h**

### **Clinical Pearls:**
- **Never delay antibiotics** for imaging or LP
- **Dexamethasone** only beneficial if given BEFORE/WITH antibiotics
- **Vancomycin + ceftriaxone** = standard adult empiric regimen
- **Add ampicillin** if >50 years (Listeria)
- **Ceftriaxone dose: 2g q12h** (higher than usual for meningitis)

## Sources

- [IDSA: Bacterial Meningitis Practice Guidelines]
- [ESCMID: Community-Acquired Bacterial Meningitis]

## Media

N/A
